New study aims to uncover hidden clues in Friedreich's ataxia
NCT ID NCT02497534
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how Friedreich's ataxia affects the heart and nerves using advanced imaging, exercise tests, and biopsies. Researchers will track 203 people with the condition to find better ways to measure disease progression. The goal is to improve future treatment studies, not to test a new therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to measure and track Friedreich's ataxia progression, helping future treatment trials.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve symptoms, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRIEDREICH'S ATAXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida
RECRUITINGGainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can advanced heart scans predict the biggest killer in Friedreich's ataxia?
- Experimental drug aims to halt rare neurological decline
- New brain scans could reveal hidden clues in rare nerve disease
- Genetic clues may predict when Friedreich's ataxia begins
- Can a supplement and exercise improve stamina in Friedreich's ataxia?
- Exercise and drug combo may fight fatigue in rare disease